Preclinical evaluation of a microparticle-based transdermal vaccine patch against metastatic breast cancer
- 29 September 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 627, 122249
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Vaccine adjuvant formulations: A pharmaceutical perspectiveSeminars in Immunology, 2013
- Formulation and evaluation of oral microparticulate ovarian cancer vaccinesVaccine, 2012
- An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based VaccinesJournal of Drug Delivery, 2011
- Improvement of different vaccine delivery systems for cancer therapyMolecular Cancer, 2011
- MF59™ as a vaccine adjuvant: a review of safety and immunogenicityExpert Review of Vaccines, 2010
- Targeted delivery of antigens to the gut-associated lymphoid tissues: 2.Ex vivoevaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patchesJournal of Microencapsulation, 2010
- The Role of Regulatory T Cells in CancerImmune Network, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- Potent Antigen-specific Immune Responses Stimulated by Codelivery of CpG ODN and Antigens in Degradable MicroparticlesJournal of Immunotherapy, 2007
- Challenges for cancer vaccine developmentAdvanced Drug Delivery Reviews, 2006